123 related articles for article (PubMed ID: 29808993)
1. Injectable Hydrogels Coencapsulating Granulocyte-Macrophage Colony-Stimulating Factor and Ovalbumin Nanoparticles to Enhance Antigen Uptake Efficiency.
Sun Z; Liang J; Dong X; Wang C; Kong D; Lv F
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20315-20325. PubMed ID: 29808993
[TBL] [Abstract][Full Text] [Related]
2. Nano-hydroxyapatite-evoked immune response synchronized with controllable immune adjuvant release for strengthening melanoma-specific growth inhibition.
Chen Z; Deng J; Cao J; Wu H; Feng G; Zhang R; Ran B; Hu K; Cao H; Zhu X; Zhang X
Acta Biomater; 2022 Jun; 145():159-171. PubMed ID: 35398268
[TBL] [Abstract][Full Text] [Related]
3. Modularly engineered injectable hybrid hydrogels based on protein-polymer network as potent immunologic adjuvant in vivo.
Giang Phan VH; Duong HTT; Thambi T; Nguyen TL; Turabee MH; Yin Y; Kim SH; Kim J; Jeong JH; Lee DS
Biomaterials; 2019 Mar; 195():100-110. PubMed ID: 30623788
[TBL] [Abstract][Full Text] [Related]
4. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
[TBL] [Abstract][Full Text] [Related]
5. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
[TBL] [Abstract][Full Text] [Related]
6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
7. Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma.
Song H; Huang P; Niu J; Shi G; Zhang C; Kong D; Wang W
Biomaterials; 2018 Mar; 159():119-129. PubMed ID: 29324304
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive thermosensitive hydrogel for the intra-tumoral delivery of immunomodulatory agents, in vivo evidence of adhesion by means of non-invasive imaging techniques.
Lemdani K; Seguin J; Lesieur C; Al Sabbagh C; Doan BT; Richard C; Capron C; Malafosse R; Boudy V; Mignet N
Int J Pharm; 2019 Aug; 567():118421. PubMed ID: 31176849
[TBL] [Abstract][Full Text] [Related]
9. Real-Time Imaging Tracking of a Dual Fluorescent Vaccine Delivery System Based on Ovalbumin Loaded Zinc Phthalocyanine-Incorporated Copolymer Nanoparticles.
Wei C; Dong X; Liang J; Zhang Y; Zhu D; Kong D; Lv F
J Biomed Nanotechnol; 2019 Jan; 15(1):100-112. PubMed ID: 30480518
[TBL] [Abstract][Full Text] [Related]
10. In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice.
Liu Y; Xiao L; Joo KI; Hu B; Fang J; Wang P
Biomacromolecules; 2014 Oct; 15(10):3836-45. PubMed ID: 25207465
[TBL] [Abstract][Full Text] [Related]
11. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
Zhai Y; Zhou Y; Li X; Feng G
Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
[TBL] [Abstract][Full Text] [Related]
12. [Effects of cell-mediated immunity induced by intramuscular chitosan-pJME/ GM-CSF nano-DNA vaccine in BAlb/c mice].
Zhai YZ; Zhou Y; Ma L; Feng GH
Bing Du Xue Bao; 2014 Jul; 30(4):423-8. PubMed ID: 25272598
[TBL] [Abstract][Full Text] [Related]
13. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner AM; Corthésy B; Merkle HP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response.
Nguyen CL; Bui JT; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
J Immunother; 2001; 24(5):420-9. PubMed ID: 11696697
[TBL] [Abstract][Full Text] [Related]
15. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
[TBL] [Abstract][Full Text] [Related]
16. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
17. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
[TBL] [Abstract][Full Text] [Related]
19. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.
Shaughnessy PJ; Bachier C; Lemaistre CF; Akay C; Pollock BH; Gazitt Y
Stem Cells; 2006 Jul; 24(7):1789-97. PubMed ID: 16822885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
